May 2, 2019
Gilead net income $2B
@GileadSciences said Thursday its total revenues were $5.3 billion in 2019 compared to $5.1 billion in 2018, with net income of $2.0 billion compared to $1.5 billion in 2018.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: results
April 30, 2019
Vertex total product revenues increased 34%,driven by SYMDEKO in the U.S. in first-quarter 2019
– First-quarter 2019 product revenues of $857 million, a 34% increase compared to $638 million in 2018- – First-quarter 2019…
April 30, 2019
Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition
CINCINNATI–(BUSINESS WIRE)–Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter and first six months ended March…
April 30, 2019
Merck 2019 Full-Year Revenue Range to be Between$43.9 Billion and $45.1 Billion
First-Quarter 2019 Worldwide Sales Were $10.8 Billion, an Increase of8%; Sales Increased 11% Excluding Negative Impact from ForeignExchange; Growth Driven by Oncology and Vaccines
April 30, 2019
PFIZER REPORTS FIRST-QUARTER 2019 RESULTS
First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and…
April 30, 2019
Incyte Reports 2019 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Total revenues of $498 million (+30% vs Q1 2018) and total product-related revenues of $458 million (+20% vs Q1 2018) for the…
April 30, 2019
Sinovac second half 2018 sales remains same, 2018 annual report on Form 20-F
Revenuegenerated by Hepatitis A vaccine increased by $12.0 million comparedto same period in 2017, which was offset by $13.6 million decrease in
April 25, 2019
Celgene Reports First Quarter 2019 Operating and Financial Results
Celgene posts strong double-digit top- and bottom-line growth across portfolioand geographies
April 25, 2019
Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m.…
April 25, 2019
Seattle Genetics Reports First Quarter 2019 Financial Results
-ADCETRIS® (Brentuximab Vedotin) Net Sales in U.S. and Canada Were $135.0 Million in the First Quarter, an Increase of 42…